SEC Form 4 · accession 0001246360-15-003503
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert S. Brown
Officer — President, NxStage Kidney Care
Period of report
Nov 3, 2015
Accepted (ET)
Nov 4, 2015 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 3, 2015 | M | 44,400 | $9.96 | A | 104,177 | D | |
| Common Stock | Nov 3, 2015 | S | 44,400 | $19.00 | D | 59,777 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $9.96 | Nov 3, 2015 | M | 44,400 | D | Apr 3, 2010 | Mar 2, 2017 | Common Stock | 44,400 | 0 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2015.